Personal wellness company WeightWatchers (NASDAQ: WW) reported Q4 CY2025 results topping the market’s revenue expectations, but sales fell by 11.7% year on year to $162.8 million. On the other hand, the company’s full-year revenue guidance of $627.5 million at the midpoint came in 0.7% below analysts’ estimates. Its GAAP loss of $0.58 per share was 71.4% above analysts’ consensus estimates.
Is now the time to buy WeightWatchers? Find out by accessing our full research report, it’s free.
WeightWatchers (WW) Q4 CY2025 Highlights:
- Revenue: $162.8 million vs analyst estimates of $149.8 million (11.7% year-on-year decline, 8.7% beat)
- EPS (GAAP): -$0.58 vs analyst estimates of -$2.03 (71.4% beat)
- Adjusted EBITDA: $18.04 million vs analyst estimates of $12.11 million (11.1% margin, 48.9% beat)
- EBITDA guidance for the upcoming financial year 2026 is $110 million at the midpoint, below analyst estimates of $115.1 million
- Operating Margin: -7.9%, down from 8.7% in the same quarter last year
- Free Cash Flow Margin: 0.7%, down from 2.4% in the same quarter last year
- Market Capitalization: $210.5 million
“Our industry is undergoing a profound transformation driven by GLP-1 medications, and Weight Watchers is evolving alongside it,” said Tara Comonte, CEO of Weight Watchers.
Company Overview
Known by many for its old cable television commercials, WeightWatchers (NASDAQ: WW) is a wellness company offering a range of products and services promoting weight loss and healthy habits.
Revenue Growth
A company’s long-term sales performance is one signal of its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. WeightWatchers’s demand was weak over the last five years as its sales fell at a 12.4% annual rate. This wasn’t a great result and is a sign of poor business quality.
Long-term growth is the most important, but within consumer discretionary, product cycles are short and revenue can be hit-driven due to rapidly changing trends and consumer preferences. WeightWatchers’s annualized revenue declines of 10.6% over the last two years suggest its demand continued shrinking. 
This quarter, WeightWatchers’s revenue fell by 11.7% year on year to $162.8 million but beat Wall Street’s estimates by 8.7%.
Looking ahead, sell-side analysts expect revenue to decline by 10.8% over the next 12 months, similar to its two-year rate. This projection is underwhelming and implies its newer products and services will not accelerate its top-line performance yet.
ONE MORE THING: 3 Hidden Platforms Growing 3X Faster than Amazon, Google, and PayPal. Amazon, Google, and Meta all followed the same playbook: Dominate an ignored market. Build an unbeatable moat. Scale until you’re unstoppable.
These three platforms are running that exact playbook right now. The early investors in Amazon made fortunes. The early investors in these could do the same. Get All 3 Stocks Here for FREE.
Operating Margin
Operating margin is an important measure of profitability as it shows the portion of revenue left after accounting for all core expenses – everything from the cost of goods sold to advertising and wages. It’s also useful for comparing profitability across companies with different levels of debt and tax rates because it excludes interest and taxes.
WeightWatchers’s operating margin has been trending down over the last 12 months and averaged 10.4% over the last two years. The company’s profitability was mediocre for a consumer discretionary business and shows it couldn’t pass its higher operating expenses onto its customers.
In Q4, WeightWatchers generated an operating margin profit margin of negative 7.9%, down 16.6 percentage points year on year. This contraction shows it was less efficient because its expenses increased relative to its revenue.
Cash Is King
If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.
While WeightWatchers’s free cash flow broke even this quarter, the broader story hasn’t been so clean. Over the last two years, WeightWatchers’s demanding reinvestments to stay relevant have drained its resources, putting it in a pinch and limiting its ability to return capital to investors. Its free cash flow margin averaged negative 3.4%, meaning it lit $3.37 of cash on fire for every $100 in revenue.
WeightWatchers broke even from a free cash flow perspective in Q4. The company’s cash profitability regressed as it was 1.7 percentage points lower than in the same quarter last year, but it’s still above its two-year average. We wouldn’t read too much into this quarter’s decline because investment needs can be seasonal, causing short-term swings. Long-term trends are more important.
Looking forward, analysts predict WeightWatchers will generate cash on a full-year basis. Their consensus estimates imply its free cash flow margin of negative 4% for the last 12 months will increase to positive 9.1%, giving it more optionality.
Key Takeaways from WeightWatchers’s Q4 Results
It was good to see WeightWatchers beat analysts’ EPS expectations this quarter. We were also excited its EBITDA outperformed Wall Street’s estimates by a wide margin. On the other hand, its full-year EBITDA guidance missed and its full-year revenue guidance fell slightly short of Wall Street’s estimates. Overall, this print was mixed. The stock traded up 2.7% to $21.67 immediately following the results.
WeightWatchers put up rock-solid earnings, but one quarter doesn’t necessarily make the stock a buy. Let’s see if this is a good investment. If you’re making that decision, you should consider the bigger picture of valuation, business qualities, as well as the latest earnings. We cover that in our actionable full research report which you can read here (it’s free).
